Table 4 Comparison of baseline data in patients with cardiac rehabilitation
Non-MACE (n = 72) | MACE (n = 6) | P | |
|---|---|---|---|
Sex, male (%) | 49 (68.1%) | 4 (66.7%) | 1.000 |
Age (years) | 58.93 ± 9.52 | 52.33 ± 6.95 | 0.103 |
History of hypertension, n (%) | 39 (54.2%) | 3 (50.0%) | 1.000 |
History of diabetes, n (%) | 16 (22.2%)* | 4 (66.7%) | 0.035 |
Smoking history, n (%) | 40 (55.6%) | 4 (66.7%) | 0.691 |
History of stroke, n (%) | 3 (4.2%) | 0 (0.0%) | 1.000 |
WBC (109/l), median (IQR) | 9.55 (7.55, 12.35) | 7.28 (5.34, 11.55) | 0.195 |
Platelet(109/l) | 230.4 ± 64.39 | 240.33 ± 73.55 | 0.721 |
HGB(g/l) | 140.77 ± 18.53 | 134.00 ± 21.68 | 0.400 |
Blood potassium (mmol/l), median (IQR) | 3.96 (3.66, 4.17)* | 4.31 (3.96, 4.63) | 0.043 |
Urea nitrogen(mmol/l) | 5.70 ± 1.57 | 5.30 ± 1.11 | 0.546 |
Creatinine (umol/l), median (IQR) | 71.05 (57.90, 88.80) | 73.80 (62.03, 129.95) | 0.579 |
AST (U/l), median (IQR) | 70.35 (29.43, 203.52) | 70.50 (33.60, 167.83) | 0.751 |
ALT (U/l), median (IQR) | 41.40 (23.30, 65.30) | 66.25 (35.38, 102.98) | 0.111 |
HDL-C (mmol/l) | 1.17 ± 0.25 | 0.99 ± 0.18 | 0.106 |
Non-HDL-C (mmol/l), median (IQR) | 3.48 (3.01, 4.18) | 3.51 (3.01, 4.39) | 1.000 |
TC (mmol/l), median (IQR) | 1.40 (1.08, 2.00) | 1.67 (1.05, 3.63) | 0.559 |
FBS (mmol/l), median (IQR) | 6.47 (5.16, 8.25) | 6.20 (5.26, 7.77) | 0.882 |
EDLV (mm) | 53.66 ± 6.22 | 55.33 ± 5.28 | 0.526 |
EF (%), median (IQR) | 42 (39, 46) | 38.5 (31.5, 46.0) | 0.179 |
HFrEF, n (%) | 51 (70.8%) | 4 (66.7%) | 1.000 |
KILLIP class | |||
I, n (%) | 0 (0.0%) | 0 (0.0%) | – |
II, n (%) | 34 (47.2%) | 4 (66.7%) | 0.425 |
III, n (%) | 23 (31.9%) | 2 (33.3%) | 1.000 |
IV, n (%) | 15 (20.8%) | 0 (0.0%) | 0.590 |
Target lesion location | |||
LAD, n (%) | 49 (68.1%) | 2 (33.3%) | 0.174 |
LCX, n (%) | 3 (4.2%) | 1 (16.7%) | 0.279 |
RCA, n (%) | 20 (27.8%) | 3 (50.0%) | 0.353 |
Rehospitalization, n (%) | 0 (0.0%)** | 6 (100.0%) | < 0.001 |
Myocardial infarction, n (%) | 0 (0.0%)** | 2 (33.3%) | 0.005 |
Heart failure, n (%) | 0 (0.0%)** | 4 (66.7%) | < 0.001 |
Stroke, n (%) | 0 (0.0%) | 0 (0.0%) | – |
R-HR (bpm), median (IQR) | 72 (67, 81) | 79 (56, 90.5) | 0.751 |
E-HR(bpm), median (IQR) | 95 (87, 109) | 105.5 (89.75, 118.25) | 0.317 |
E-VE (l/min), median (IQR) | 28.95 (25.45, 34.00) | 30.95 (22.88, 35.42) | 0.913 |
â–³VE (l/min), median (IQR) | 16.80 (13.73, 21.20) | 15.20 (10.93, 21.88) | 0.586 |
VE/MVV (%), median (IQR) | 28 (25.25, 31.75) | 29.5 (20.5, 36.25) | 0.992 |
VO2 at VT (ml/kg/min), median (IQR) | 9 (10, 11) | 9 (7.5, 11) | 0.135 |
E-VCO2 (l/min), median (IQR) | 0.70 (0.61, 0.85) | 0.64 (0.47, 0.82) | 0.383 |
â–³CO2 (l/min), median (IQR) | 0.49 (0.38, 0.57) | 0.39 (0.25, 0.56) | 0.175 |
VE/VCO2 slope, median (IQR) | 35.10 (32.53, 38.89) | 36.34 (35.98, 42.86) | 0.181 |
R-PETCO2 (mmHg), median (IQR) | 29 (28, 30) | 28 (26.25, 30.25) | 0.254 |
PETCO2 at VT (mmHg), median (IQR) | 33 (32, 34)* | 32 (29, 33) | 0.016 |
â–³PETCO2 (mmHg), median (IQR) | 4 (3, 5) | 3 (1.25, 4.25) | 0.107 |